Table 2.
Total cohort (n = 15) | VD (n = 8) | CSD (n = 7)a | |
---|---|---|---|
INFANT CHARACTERISTICS | |||
Female gender | 7 (46.7%) | 5 (62.5%) | 2 (28.6%) |
Gestational age at delivery (weeks) | 38.7 ± 1.8 | 39 ± 1.5 | 38.3 ± 2.1 |
Birth weight (g) | 3273 ± 416 | 3311 ± 543 | 3230 ± 236 |
MATERNAL CHARACTERISTICS | |||
Positive group B Streptococcus screening | 3 (21.4%) | 3 (37.5%) | 0 |
Age | 33.6 ± 4.6 | 32.5 ± 4.4 | 35 ± 4.8 |
Postnatal body mass index | 24 ± 4.3 | 21.8 ± 2.7 | 26.8 ± 4.6 |
ETHNICITY | |||
Caucasian | 12 (85.7%) | 7 (87.5%) | 5 (83.3%) |
African | 2 (14.3%) | 1 (12.5%) | 1 (16.7%) |
Perinatal antibiotic intakeb | 11 (78.6%) | 6 (75%) | 5 (83.3%) |
Penicillinc | 6 (42.9%) | 6 (75%) | 0 |
Cephalosporin | 4 (28.6%) | 0 | 4 (66.7%) |
Clindamycin | 1 (7.1%) | 0 | 1 (16.7%) |
Probiotic use during pregnancy | 2 (14.3%) | 1 (12.5%) | 1 (16.7%) |
2 C-section infants are twins.
Considering all antibiotics administered to the mother 12 h prior and after the delivery.
As ampicillin belongs to the penicillin group, ampicillin and penicillin intake were both categorized as “penicillin.”
Study groups are defined according to delivery mode (VD: n = 8; CSD: n = 7). CSD, C-section delivery; VD, vaginal delivery.